Erba Mannheim Announces Availability of Validated Automated Protocols for ErbaLisa COVID-19 IgG and IgM ELISA Kits
Erba Mannheim (London, England) has announced availability of validated automated protocols for its range of ErbaLisa COVID-19 IgG and IgM ELISA kits in order to improve global availability of high-quality testing methods for SARS-CoV-2. More...01 Sep 2020
SARS-CoV-2 Serology Assay Evaluations Indicate Seropositivity Increases with Time After Symptom Onset
A head-to-head evaluation of a dozen SARS-CoV-2 serology assays has revealed several variables in their test performance, including increasing seropositivity with increasing time from symptom onset and a range of test specificities. More...31 Aug 2020
Thermo Fisher Opens New Plant for Manufacturing COVID-19 Sample Collection Products
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has officially opened its new USD 40 million manufacturing plant in Lenexa, Kansas, USA for the production of viral transport media (VTM) that will continue to be expanded to meet the expected sustained demand for COVID-19 testing. More...31 Aug 2020
Researchers Warn Against Targeting Only One Viral Gene for SARS-CoV-2 Detection by RT-PCR Due to Mutation in N Gene
Researchers have warned against targeting only one viral gene when carrying out reverse transcriptase-polymerase chain reaction (RT-PCR) testing for the SARS-CoV-2 virus, according to a report by News Medical. More...31 Aug 2020
New COVID-19 Test Shows Patients with Suppressed Immune Systems Can Also Achieve Good Immune Response to SARS-CoV-2
A new test that provides information on the immune response to the novel coronavirus in patients who need to take immunosuppressive drugs has shown that these patients can achieve a good immune response to SARS-CoV-2 despite immunosuppression. More...31 Aug 2020
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Auto-Chemistry Analyzer
CS-1200
New
PSA Test
Human Semen Rapid Test
In Other News
New Pooling Strategy Increases Efficiency and Reduces Cost of COVID-19 PCR Tests
AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks
New CE-Marked ELISA Test Detects COVID-19 Antibodies in Recently Infected People with Mild Symptoms
First-of-Its-Kind Mobile Testing Platform Launched to Manage and Track On-Site COVID-19 Testing
Abbott's USD 5, 15-Minute BinaxNOW COVID-19 Ag Card Becomes First Diagnostic Test with Read-Result Test Card to Receive FDA EUA
Coronavirus Screening Platform Uses Machine Learning Algorithms to Detect SARS-CoV-2 Structural Fingerprint in Real Time
Fluidigm’s Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay Secures FDA Emergency Use Authorization
Novel Coronavirus Breathalyzer Test Detects COVID-19 Non-Invasively in Seconds
Novel SERS Assay Could Identify Superspreaders Carrying Coronavirus Mutations
First-Ever Saliva-Based COVID and Influenza Combo Test to Screen for Coronavirus and Flu Infections
New COVID-19 Pooling Test Method Identifies Asymptomatic Carriers
Zymo Research’s Quick SARS-CoV-2 rRT-PCR Kit Receives CE-IVD Mark
Beckman Coulter Launches New SARS-CoV-2 Immunoglobulin M (IgM) Antibody Test
Use of COVID-19 Tests without FDA Approval Could Bring New, Innovative Tests to Market More Quickly
OpGen Launches Own-Developed CE-IVD Marked Molecular Diagnostic SARS-CoV-2 Kit with PULB in Europe
COVID-19 Fuelling Growth of In-Vitro Diagnostics Market and Creating Novel Opportunities for Players
Tests to Detect Common Immune Signature in Blood of COVID-19 Patients Could Predict Severity of Disease
LumiraDx SARS-CoV-2 Antigen Test Granted FDA Emergency Use Authorization
Quidel’s Point-of-Care Sofia SARS Antigen FIA Test for COVID-19 to Offer New Kit Configuration
Ultra-High-Volume COVID-19 Test to Enable Genomic Diagnostic Testing and Population Screening For 40,000 Samples per Day
QIAGEN Launches QIAseq SARS-CoV-2 Primer Panel for Next-Generation Sequencing Of Novel Coronavirus Genome to Accelerate COVID-19 Research
Accelerate Diagnostics’ COVID-19 Antibody Testing System Granted FDA Emergency Use Authorization
Diazyme Secures Second FDA Emergency Use Authorization for COVID-19 Antibody Test
